Tarsus Pharmaceuticals (TARS) Treasury Shares (2019 - 2020)

Tarsus Pharmaceuticals' Treasury Shares history runs 8 years deep, the most recent figure standing at $721325.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 62.65% year-over-year to $721325.0; the TTM figure through Mar 2026 stood at $721325.0 (down 62.65% YoY), while the FY2025 annual figure was $1.8 million, down 8.3% from the prior year.
• Treasury Shares for Q1 2026 stood at $721325.0, down from $1.8 million in the prior quarter.
• The five-year high for Treasury Shares was $2.0 million in Q1 2024, with the low at $551258.0 in Q4 2022.
• The 5-year median for Treasury Shares is $1.7 million (2023), against an average of $1.4 million.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 3095.51% in 2022, then tumbled 63.55% in 2025.
• Tarsus Pharmaceuticals' Treasury Shares stood at $551258.0 in 2022, then surged by 209.97% to $1.7 million in 2023, then increased by 12.09% to $1.9 million in 2024, then decreased by 8.3% to $1.8 million in 2025, then sank by 58.93% to $721325.0 in 2026.
• Business Quant data shows TARS's Treasury Shares at $721325.0 in Q1 2026, $1.8 million in Q4 2025, and $714806.0 in Q3 2025.